Reset all filters
01 1ANACAULASE-BCDB
02 2Bromelainer
03 2Concentrate Of Proteolytic Enzymes Enriched In Bromelain
Reset all filters
01 1MEDIWOUND, LTD
02 4Mediwound Germany Gmbh
Reset all filters
01 1GEL;TOPICAL
02 2Gel
03 2Powder And Gel For Gel
Reset all filters
01 12G
02 15G
03 15g
04 18.8%
05 1Blank
Reset all filters
01 2Spain
02 2Sweden
03 1USA
Regulatory Info :
Registration Country : USA
Dosage Form : GEL;TOPICAL
Brand Name : NEXOBRID
Dosage Strength : 8.8%
Packaging :
Approval Date :
Application Number : 761192
Regulatory Info :
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Gel
Brand Name : Nexobrid
Dosage Strength :
Packaging :
Approval Date : 18/12/2012
Application Number : 20110809000393
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Gel
Brand Name : Nexobrid
Dosage Strength : 5g
Packaging :
Approval Date : 18/12/2012
Application Number : 20110809000409
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Concentrate Of Proteolytic Enzymes Enriched In Bromelain
Dosage Form : Powder And Gel For Gel
Brand Name : Nexobrid
Dosage Strength : 5G
Packaging :
Approval Date : 2014-09-15
Application Number : 112803002
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Concentrate Of Proteolytic Enzymes Enriched In Bromelain
Dosage Form : Powder And Gel For Gel
Brand Name : Nexobrid
Dosage Strength : 2G
Packaging :
Approval Date : 2014-07-14
Application Number : 112803001
Regulatory Info : Authorized
Registration Country : Spain